Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%
- PMID: 17499306
- DOI: 10.1016/j.juro.2007.03.018
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%
Abstract
Purpose: We determined the yield of standard vs limited pelvic lymphadenectomy in patients with a predicted risk of lymph node metastasis greater than 1% according to the Partin tables predicted probability of pathological stage. We also determined the feasibility of laparoscopic standard pelvic lymph node dissection.
Materials and methods: Of 1,269 patients with clinically localized prostate cancer undergoing radical prostatectomy, 648 had a Partin's table predicted probability of lymph node invasion greater than 1%. Of the 648 patients 177 underwent limited pelvic lymph node dissection performed laparoscopically (group 1), and 471 underwent standard pelvic lymph node dissection performed open (367) or laparoscopically (104) (group 2). Templates of limited pelvic lymph node dissection included the external iliac lymph nodes whereas standard pelvic lymph node dissection included the external iliac, obturator and hypogastric lymph nodes. Multivariate logistic regression analyses were performed to compare the node positivity rate between groups 1 and 2.
Results: On multivariate logistic regression analysis controlling for prostate specific antigen, biopsy Gleason sum, clinical stage and surgical approach, the odds of node positivity were 7.15-fold higher (95% CI 2.49-20.5, p<0.001) for standard vs limited pelvic lymph node dissection. The median (mean) number of nodes retrieved was 9 (10) and 14 (15) after limited and standard pelvic lymph node dissection, respectively (p<0.001). A similar impact was observed in patients treated laparoscopically with standard vs limited pelvic lymph node dissection (odds ratio 15.6, 95% CI 3.7-66.4, p<0.001).
Conclusions: Standard lymph node dissection yields positive nodes more frequently and retrieves a higher total nodal count than the often performed pelvic lymph node dissection limited to the external iliac nodes. Standard pelvic lymph node dissection is feasible through a transperitoneal laparoscopic approach.
Comment in
-
Should patients with prostate cancer and a risk of nodal metastasis >1% undergo standard or limited PLND?Nat Clin Pract Urol. 2008 Jan;5(1):10-1. doi: 10.1038/ncpuro0943. Epub 2007 Oct 16. Nat Clin Pract Urol. 2008. PMID: 17940528 No abstract available.
-
Re: Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1% K. Touijer, F. Rabbani, J. R. Otero, F. P. Secin, J. A. Eastham, P. T. Scardino And B. Guillonneau J Urol 2007; 178: 120-124.J Urol. 2008 Feb;179(2):789-90. doi: 10.1016/j.juro.2007.09.101. Epub 2007 Dec 20. J Urol. 2008. PMID: 18082824 No abstract available.
Similar articles
-
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.J Urol. 2002 Apr;167(4):1681-6. J Urol. 2002. PMID: 11912387
-
Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.Aktuelle Urol. 2010 Jan;41 Suppl 1:S10-4. doi: 10.1055/s-0029-1224663. Epub 2010 Jan 21. Aktuelle Urol. 2010. PMID: 20094944
-
Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.Eur Urol. 2007 Nov;52(5):1347-55. doi: 10.1016/j.eururo.2007.04.073. Epub 2007 May 2. Eur Urol. 2007. PMID: 17507150
-
Pelvic node dissection in prostate cancer: extended, limited, or not at all?Curr Opin Urol. 2010 May;20(3):211-7. doi: 10.1097/MOU.0b013e328338405d. Curr Opin Urol. 2010. PMID: 20224412 Review.
-
Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram.Can J Urol. 2011 Apr;18(2):5585-91. Can J Urol. 2011. PMID: 21504645 Review.
Cited by
-
Sentinel node evaluation in prostate cancer.Clin Exp Metastasis. 2018 Aug;35(5-6):471-485. doi: 10.1007/s10585-018-9936-4. Epub 2018 Sep 5. Clin Exp Metastasis. 2018. PMID: 30187286 Review.
-
THE ROLE OF LYMPHADENECTOMY IN PROSTATE CANCER PATIENTS.Acta Clin Croat. 2019 Nov;58(Suppl 2):24-35. doi: 10.20471/acc.2019.58.s2.05. Acta Clin Croat. 2019. PMID: 34975195 Free PMC article. Review.
-
External Validation of the Briganti Nomogram to Predict Lymph Node Invasion in Prostate Cancer-Setting a New Threshold Value.Life (Basel). 2021 May 25;11(6):479. doi: 10.3390/life11060479. Life (Basel). 2021. PMID: 34070313 Free PMC article.
-
Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.Eur Urol Oncol. 2021 Aug;4(4):532-539. doi: 10.1016/j.euo.2021.03.006. Epub 2021 Apr 15. Eur Urol Oncol. 2021. PMID: 33865797 Free PMC article. Clinical Trial.
-
A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.BJU Int. 2013 Feb;111(2):206-12. doi: 10.1111/j.1464-410X.2012.11638.x. BJU Int. 2013. PMID: 23356747 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical